Akèy › Maladi selil fòs › Georgia › Augusta
Etid klinik pou Maladi selil fòs nan Augusta, GA
5 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Augusta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
- Augusta University Georgia, Augusta
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Ap rekriteFaz 1
- Augusta University, Augusta
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Ap rekriteFaz 4
- Augusta University Georgia, Augusta
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Ap rekriteFaz 1
- Augusta University, Augusta
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- Augusta University, Augusta
Etid Maladi selil fòs nan lòt vil
- Atlanta, GA22 etid
- Washington, DC20 etid
- Memphis, TN18 etid
- Chicago, IL18 etid
- Philadelphia, PA15 etid
- Birmingham, AL14 etid
- New York City, NY13 etid
- St. Louis, MO12 etid
- Durham, NC10 etid
- Cincinnati, OH10 etid
- Houston, TX10 etid
- Boston, MA10 etid
Lòt etid nan Augusta
- Leksemi mieloïd egi10 etid
- Kansè ovè8 etid
- Kansè Endomèt7 etid
- Kansè (tout kalite)7 etid
- Kansè nan tete5 etid
- Miasteni grav4 etid
- Kansè san4 etid
- Limfòm Burkitt4 etid
- Limfom Difize Gwo Selil B4 etid
- Lukemi miyoyid kwonik4 etid
- Limfòm Non-Hodgkin4 etid
- Kansè kol4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.